Difference between revisions of "Team:San Andres"
| Line 6: | Line 6: | ||
</head> | </head> | ||
<body> | <body> | ||
| + | <meta content="text/html; charset=ISO-8859-1" | ||
| + | http-equiv="content-type"> | ||
| + | <title></title> | ||
<meta content="text/html; charset=ISO-8859-1" | <meta content="text/html; charset=ISO-8859-1" | ||
http-equiv="content-type"> | http-equiv="content-type"> | ||
| Line 689: | Line 692: | ||
<div class="gwd-div-7xzo gwd-a-1thu"> | <div class="gwd-div-7xzo gwd-a-1thu"> | ||
<h1>Abstract</h1> | <h1>Abstract</h1> | ||
| − | <big>The celiac disease affects 1 in 265 people worldwide and 15% | + | <div style="text-align: justify;"><big>The celiac |
| + | disease affects 1 in 265 people worldwide and 15% | ||
of population in Chile. This in an irreversible autoimmune disease in | of population in Chile. This in an irreversible autoimmune disease in | ||
which due to the presence of genes HLA DQ2 or HLA DQ8 in those | which due to the presence of genes HLA DQ2 or HLA DQ8 in those | ||
| Line 697: | Line 701: | ||
absorption, among others) significantly affecting their quatily of life.</big> | absorption, among others) significantly affecting their quatily of life.</big> | ||
<br> | <br> | ||
| − | + | <br> | |
| − | Whereas the majority of the world food contains gluten, we propose a | + | <big>Whereas the majority of the world food contains gluten, we |
| + | propose a | ||
treatment for those who can't eat gluten, and can do so without | treatment for those who can't eat gluten, and can do so without | ||
problems. In detail, our project involves a system able to degrade | problems. In detail, our project involves a system able to degrade | ||
| Line 706: | Line 711: | ||
improve the quality of life of all those reported with celiac disease. | improve the quality of life of all those reported with celiac disease. | ||
People who suffer from gluten intolerance have an adverse reaction to | People who suffer from gluten intolerance have an adverse reaction to | ||
| − | gluten proteins found in wheat, barley, and rye products.<br> | + | gluten proteins found in wheat, barley, and rye products.</big><br> |
| − | <br> | + | </div> |
| + | <big><br> | ||
</big> | </big> | ||
<div style="text-align: center;"><img | <div style="text-align: center;"><img | ||
| Line 727: | Line 733: | ||
src="https://static.igem.org/mediawiki/2015/thumb/9/94/Logo43.png/454px-Logo43.png" | src="https://static.igem.org/mediawiki/2015/thumb/9/94/Logo43.png/454px-Logo43.png" | ||
class="gwd-img-l2p5"></a><br> | class="gwd-img-l2p5"></a><br> | ||
| + | <br> | ||
<br> | <br> | ||
<br> | <br> | ||
</body> | </body> | ||
</html> | </html> | ||
Revision as of 23:15, 19 August 2015
| Home | Team | Project | Parts | Modeling |
| Results | Notebook | Human Practices | Future Projections | Collaborations |
Abstract
The celiac
disease affects 1 in 265 people worldwide and 15%
of population in Chile. This in an irreversible autoimmune disease in
which due to the presence of genes HLA DQ2 or HLA DQ8 in those
affected, the consumption of foods containing gluten (all fods derived
from wheat, barley, rye, etc.) cause an inflammation in small intestine
causing multiple effects in the organism (diarrhea, constipation, porr
absorption, among others) significantly affecting their quatily of life.
Whereas the majority of the world food contains gluten, we propose a treatment for those who can't eat gluten, and can do so without problems. In detail, our project involves a system able to degrade gluten via the enzyme KumaMax and report the operation simultaneously with a red fluorescent protein. The foregoing, works in a genetically modified E. coli bacteria. With this project, in long run, we hope to improve the quality of life of all those reported with celiac disease. People who suffer from gluten intolerance have an adverse reaction to gluten proteins found in wheat, barley, and rye products.
Whereas the majority of the world food contains gluten, we propose a treatment for those who can't eat gluten, and can do so without problems. In detail, our project involves a system able to degrade gluten via the enzyme KumaMax and report the operation simultaneously with a red fluorescent protein. The foregoing, works in a genetically modified E. coli bacteria. With this project, in long run, we hope to improve the quality of life of all those reported with celiac disease. People who suffer from gluten intolerance have an adverse reaction to gluten proteins found in wheat, barley, and rye products.
